A
Alnylam Pharmaceuticals, Inc. (ALNY)
NMS – Real vaqt narxi. Valyuta: USD
292.03
+7.19 (2.52%)
Yopilishda: May 12, 2026, 4:00 PM EDT
290.27
-1.76 (-0.60%)
Bozor oldidan: May 13, 2026, 7:52 AM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
292.03
+7.19 (2.52%)
Yopilishda: May 12, 2026, 4:00 PM EDT
290.27
-1.76 (-0.60%)
Bozor oldidan: May 13, 2026, 7:52 AM EDT
This stock has a consensus price target of $463.70 based on the ratings of 31 analysts. The high is $583.00 and the low is $310.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 310 | $ 463.7 | $ 583 |
| O’zgarish | 6.15% | 58.79% | 99.64% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-05-05 | 75.7% | HC Wainwright & Co. | $510 → $510 | Reiterates | Buy |
| 2026-05-01 | 53.31% | RBC Capital | $450 → $445 | Maintains | Outperform |
| 2026-05-01 | 29.88% | Wells Fargo | $376 → $377 | Maintains | Equal-Weight |
| 2026-04-13 | 73.98% | Truist Securities | $515 → $505 | Maintains | Buy |
| 2026-03-25 | 46.42% | Chardan Capital | $425 → $425 | Maintains | Buy |